US Drug Recall Register
Class II · Moderate risk Completed Initiated Nov 29, 2023 (3 years ago)

ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was with the bag manufacturer who released bags Lot # 134142-001A which had failed internal QC tests for leaks.

What was recalled

ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500 mL bags, Rx only, STAQ Pharma Inc. 14135 E 42nd Ave, Unit 50, Denver, Colorado 80239, NDC 73177-0109-26,

Recalling firm
STAQ Pharma, Inc.
NDC code
73177-0109-26
Origin
CO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0147-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all